XERS

NASDAQ · Pharmaceuticals

Xeris Biopharma Holdings Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$15.20

+2.12 (+16.21%)

As of Nov 7, 10:02 PM ET ·

XERS News1 articles

Corcept Shares Leap 27% on Strong Lifyorli Launch and Upbeat Guidance

Corcept Therapeutics shares jumped 27.4% after Q2 revenue rose 32% to $256.1M, driven by Lifyorli sales of $47.6M. The company lifted its 2026 revenue outlook to $1.1-1.2 billion.

Earnings Jul 30